• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - GALWAY SYNERGY II EVEROLIMUS-ELUTING PLATINUM CHROMIUM CORONARY STENT SYSTEM; BIODEGRADABLE POLYMER DRUG ELUTING CORONARY STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - GALWAY SYNERGY II EVEROLIMUS-ELUTING PLATINUM CHROMIUM CORONARY STENT SYSTEM; BIODEGRADABLE POLYMER DRUG ELUTING CORONARY STENT SYSTEM Back to Search Results
Model Number H7493926032400
Medical Device Problem Code Device Dislodged or Dislocated (2923)
Health Effect - Clinical Code No Consequences Or Impact To Patient (2199)
Date of Event 06/11/2018
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Device is a combination product.(b)(4).
 
Event or Problem Description
It was reported that stent dislodgement occurred.The target lesion was located in the right coronary artery.A 4.00 x 32mm synergy ii drug-eluting stent was advanced but failed to cross the lesion.However, accordioned on the end of the non-bsc guide and when the device was removed from the sheath, it was noted that the stent came off the balloon.The entire system was removed from the patient and the procedure was completed with another 4.00 x 32mm synergy stent.No patient complications were reported and the patient's status was fine.
 
Additional Manufacturer Narrative
Device evaluated by mfr., eval summary attached, method codes, result codes, conclusion codes updated.Device evaluated by mfr: a synergy ii us mr 4.00 x 32mm was returned for analysis.The stent delivery system (sds) was not returned for analysis therefore individual assessment of the catheter could not be performed.The stent was returned detached from the sds and was severely stretched and damaged.No other issues were identified during the product analysis.The manufacturing batch record review confirmed that the device met all material, assembly and performance specifications.The investigation conclusion is caused by other device as another device/drug/subsequent procedure caused the complaint event.(b)(4).
 
Event or Problem Description
It was reported that stent dislodgement occurred.The target lesion was located in the right coronary artery.A 4.00 x 32mm synergy ii drug-eluting stent was advanced but failed to cross the lesion.However, accordioned on the end of the non-bsc guide and when the device was removed from the sheath, it was noted that the stent came off the balloon.The entire system was removed from the patient and the procedure was completed with another 4.00 x 32mm synergy stent.No patient complications were reported and the patient's status was fine.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY II EVEROLIMUS-ELUTING PLATINUM CHROMIUM CORONARY STENT SYSTEM
Common Device Name
BIODEGRADABLE POLYMER DRUG ELUTING CORONARY STENT SYSTEM
Manufacturer (Section D)
BOSTON SCIENTIFIC - GALWAY
MDR Report Key7664243
Report Number2134265-2018-05935
Device Sequence Number19421888
Product Code NIQ
UDI-Device Identifier08714729840374
UDI-Public08714729840374
Combination Product (Y/N)N
Initial Reporter StateTX
Initial Reporter CountryUS
PMA/510(K) Number
P150003
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 06/13/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date10/25/2018
Device Model NumberH7493926032400
Device Catalogue Number39260-3240
Device Lot Number21322639
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer06/22/2018
Initial Date Received by Manufacturer 06/13/2018
Supplement Date Received by Manufacturer07/17/2018
Initial Report FDA Received Date07/05/2018
Supplement Report FDA Received Date08/08/2018
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Patient Age89 YR
-
-